Cardiac Electrophysiologic and Hemodynamic Effects of Sildenafil, a PDE5 Inhibitor, in Anesthetized Dogs

Autor: Yoshioki Satoh, Akira Takahara, Keitaro Hashimoto, Hiroyuki Shiina, Atsushi Sugiyama, Masahiko Yoneyama
Rok vydání: 2001
Předmět:
Male
Inotrope
Chronotropic
Bundle of His
medicine.medical_specialty
Refractory Period
Electrophysiological

Phosphodiesterase Inhibitors
Sildenafil
Action Potentials
Blood Pressure
Vasodilation
Piperazines
Sildenafil Citrate
Electrocardiography
chemistry.chemical_compound
Dogs
3'
5'-Cyclic-GMP Phosphodiesterases

Heart Rate
Internal medicine
Potassium Channel Blockers
Ventricular Pressure
Animals
Repolarization
Medicine
Anesthesia
Sinus rhythm
Sulfones
Cyclic Nucleotide Phosphodiesterases
Type 5

Pharmacology
business.industry
Cardiac Pacing
Artificial

Electric Conductivity
Hemodynamics
Effective refractory period
respiratory tract diseases
chemistry
Purines
cGMP-specific phosphodiesterase type 5
Ventricular Function
Right

cardiovascular system
Cardiology
Female
Vascular Resistance
Cardiology and Cardiovascular Medicine
business
Zdroj: Journal of Cardiovascular Pharmacology. 38:940-946
ISSN: 0160-2446
Popis: Summary: A recent in vitro study demonstrated that supratherapeutic concentrations of sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, blocked I Kr and prolonged cardiac repolarization. This study assessed the in vivo cardiohemodynamic and electrophysiologic effects of sildenafil using a halothane-anesthetized, closed-chest canine model (n = 5) to bridge the gap between basic observation and clinical experience. Intravenous administration of sildenafil citrate in doses of 0.03, 0.3, and 3.0 mg/kg for 10 min, which provided sub-to supratherapeutic plasma drug concentrations, did not affect the monophasic action potential duration or effective refractory period of the right ventricle during the sinus rhythm as well as the ventricular pacing at the cycle length of 400 and 300 ms. However, sildenafil decreased the total peripheral resistance, simultaneously inducing positive chronotropic and inotropic effects at the top dose, which gave plasma concentrations at least 10 times higher than the therapeutic range. This cardiohemodynamic profile of sildenafil can be largely explained by reflex sympathetic activation associated with its vasodilator effect. Meanwhile, the lack of prolongation of the ventricular repolarization phase at the therapeutically relevant to moderately supratherapeutic sildenafil concentrations supports the earlier clinical studies that indicate that sildenafil has no effect on electrocardiogram.
Databáze: OpenAIRE